Showing results (61-70 of 438) with videos related to

Sort By:
Pageof 44
Tumori|March 13, 2019
Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational StudySara Lonardi, Guglielmo Nasti, Daniele Fagnani, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2012
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancerMarta Lucchetta, Sara Lonardi, Francesca Bergamo, et al.
Cancers|July 29, 2025
Quality of Life in Rectal Cancer Treatments: An Updated Systematic Review of Randomized Controlled Trials (2013-2023)Silvia Negro, Francesca Bergamo, Lorenzo Dell'Atti, et al.
Cancers|October 29, 2020
Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer PatientsEnrica Rampazzo, Erika Cecchin, Paola Del Bianco, et al.
Investigational New Drugs|March 1, 2018
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patientsTeresa Di Desidero, Paola Orlandi, Anna Fioravanti, et al.
BMC Cancer|July 10, 2020
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensZev A Wainberg, Kynan Feeney, Myung Ah Lee, et al.
Pathologica|July 8, 2025
Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapyJessica Gasparello, Vittoria Matilde Piva, Valentina Angerilli, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal MalignanciesLetizia Procaccio, Vera Damuzzo, Francesca Di Sarra, et al.
Expert Opinion on Biological Therapy|March 29, 2019
Ramucirumab: the long and winding road toward being an option for mCRC treatmentCeline Debeuckelaere, Sabina Murgioni, Sara Lonardi, et al.
Clinical Colorectal Cancer|October 20, 2019
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 AnalysesHeinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, et al.
Pageof 44